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1. Introduction 
1.1. Motivation for cell sorting 
The cell is the basic functional unit within a tissue or an organ. Methods that can be used to 
probe the cell, so as to understand, or even manipulate its interrelated processes, pathways, 
and/or overall functioning, are of great scientific and commercial value. Research efforts in 
molecular biology, biochemistry, and biotechnology over the last two decades have created 
high demand for efficient, cost-effective, cell enrichment, isolation, and handling methods. 
Cell studies can be performed on continuously growing cell lines, many of which are 
commercially available, in tissue culture, or on cells obtained from intact tissues or isolated 
from blood [1-3]. 
Mammalian cells are highly heterogeneous in structure, function, and characteristics. 
However, many types of biochemical, pharmaceutical, and clinical studies, such as 
immunophenotyping, studies of the cell cycle, cell proliferation, or apoptosis, and other 
specialized cell analyses require a homogenous population consisting of a single cell type; as 
the analyte. Only then can the results deemed accurate and specific to the cell type under 
investigation [4, 5]. Accordingly, techniques to separate cell types in a heterogeneous cell 
population are of immense practical value. Any such efforts are further complicated when 
the target cell is rare within a population such as in many cancer and prenatal diagnosis 
applications. The more stringent the requirements for specific and precise cell separation, 
the greater the degree of accuracy and reproducibility required in the technology that 
underlies the separation method [6-8].  
Recent progress in microfabrication, technologies developed and utilized by the integrated 
circuits (ICs) industry, is being exploited to biomedicine, spawning a relatively new field of 
research that has become known as BioMEMS. Microfabricated devices have already had a 
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broad range of biomedical and biological applications [9, 10]. These devices can be 
manufactured with a reproducible accuracy of less than 1 micrometer (1/100th the diameter 
of a human hair). In the last decade, microchips have been used in a huge range of devices 
and contexts: microscale sensors for surgical instruments, monitoring of physiological 
activities, drug discovery and delivery, DNA amplification, and electrophoresis, as well as 
cell sorting, the application discussed in this chapter [11-16].  
Microfluidic technology, a subcategory of BioMEMS, is a set of techniques and processes for 
making devices to precisely control and manipulate fluid in a geometrically small channels; 
sub- to few hundred- micrometers in size. Microfluidic is multi-disciplinary; developing a 
device with biological utility requires the integration of knowledge and techniques from the 
fields of engineering, biology, physics, and chemistry. Such microfabricated devices are 
used to study biological systems and to generate new insights into how these systems work. 
Conversely, the biological knowledge gained through micro/nano - scale analyses can lead 
to further improvements in device design. BioMEMS is a challenging field because the 
materials, and chemistries, important for biological microfluidics applications are so diverse 
[17, 18].  
The objective of the present chapter is to introduce the principals of cell sorting by 
microfluidic technology, and to discuss its strengths, current limitations, and current and 
potential applications, with illustrative examples from the literature and from the author’s 
laboratory.  
1.2. Challenges in cell sorting 
Cells of different types have characteristic sizes, shapes, densities, and arrays of surface 
molecules that can be exploited for sorting. For example, red blood cells (RBCs) are the cells 
responsible for delivering oxygen to the tissues. RBCs have to squeeze through capillaries 
and therefore are relatively small, approximately 6-8 µm in diameter, and flexible. Mature 
RBCs are anucleate; the maturing cells lose their nuclei before leaving the bone marrow. 
Loss of the nucleus leads to cell membrane collapse, conferring the characteristic biconcave 
shape of RBCs, and giving the cell a greater surface area to volume ratio than of spherical 
cells. These physical features allow easier movement of oxygen (O2) and carbon dioxide 
(CO2) through the membrane. RBCs are composed mainly of hemoglobin, whose iron atoms 
temporarily bind O2 molecules in the lungs, and then release the molecules throughout the 
body. RBCs have the highest density of any cell type in blood. All of the above 
characteristics can be used for separation: for example size can be used to separate RBCs 
since they are smaller and more flexible than white blood cells (WBCs). RBCs’ high density 
causes them to spin down to the bottom of a test tube after density gradient centrifugation. 
The high iron content gives RBCs intrinsic magnetic properties and can be used for magnetic 
separation [19].  
In other cases, a cell changes its shape or size as a result to a disease or change in function. 
In sickle-cell disease, a genetic blood disorder, RBCs assume an abnormal, rigid, sickle 
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shape. The change in shape and the increased rigidity of the RBCs lead to obstruction of 
capillaries, thereby restricting blood flow to organs, causing anemia and other “sickle cell 
crisis”, and decreasing life expectancy. Cancer is a second example of such changes [20]. 
Malignant tumor cells differ from benign tumor cells in structure, growth rate, invasiveness, 
and their ability to metastasize. Benign tumor cells grow slowly, pushing neighboring 
tissues away while staying well encapsulated. In contrast, malignant tumor cells grow 
rapidly, invade neighboring tissues, and may metastasize [21]. Furthermore, they generally 
are irregular in shape, and exhibit a more “rugged” or “ruffled” surface appearance than do 
normal cells [22, 23]. Cancer is detected and diagnosed based on physical changes present in 
tissues and cells. Nuclear changes such as an increase in size, deformation, and a change in 
internal organization are among the most universal criteria for detecting malignancy [24-25]. 
These changes may reflect alterations in the nuclear matrix and the connections of the 
nuclear matrix to or via the cytoskeleton. Cancer cells modify their morphology, principally 
by increasing the size of the nucleus, before they become invasive, i.e., in dysplasia and 
carcinoma in situ. The nucleus of a dysplastic cell can be up to four times as large as that of a 
non-dysplastic cell. Accordingly, light scattering microscopy has been used to distinguish 
normal, dysplastic, and cancerous epithelial cells in a range of tissues including esophagus, 
colon, bladder, and oral cavity [26]. However, this technique can only succeed if a sufficient 
number of cells are available for analysis. 
Additionally, most cell types have characteristic complements of surface molecules. Among 
the most useful for identification is the cluster of differentiation (CD), or cluster of 
designation. CD molecules have roles in signaling and adhesion processes, and the specific 
compliments of CD molecules is a determinant of the specific function of the cell. Cell 
populations are usually denoted by a pattern of “+” or a “-“scorings; indicating the presence 
or absence of specific CD molecules. For example, a nomenclature of CD34+, CD31- denotes a 
cell that expresses CD34 but not CD31. Use of more than one marker can make the cell 
selection very specific. However, not all cell types have a known specific surface marker 
[27]. 
For some cells such as cancer cells, not many cell-surface markers have been identified. In 
such a situation, some techniques have used a surface marker directed against surface 
membrane antigens that are expressed in tissue of origin, which is most often epithelial. 
Thus, detection of these tissue-specific surface markers in the blood stream is suggesting 
that cancer cells have detached from the tumor. Some techniques attempting to isolate 
circulating tumor cells (CTCs) from whole blood have used EpCAM, an epithelial cell 
adhesion molecule that is overexpressed in epithelial carcinomas such as colon and breast. 
However, published studies have shown inconsistent frequency of EpCAM expression in 
breast cancer, from as low as 35% to as high as 100% [28-31]. Thus, EpCAM cannot be 
considered a CTC specific marker. Additional bio-molecules such as DAPI (nucleic acid 
stain) and antibodies against cytokeratin (expressed on the epithelial cell membrane) and 
CD45 (expressed on the majority of hematopoietic cells) must be used if captured cells are to 
be positively identified as CTC. Therefore a cell with the phenotype EpCAM+, DAPI+, CK+, 
and CD45- is considered a CTC. 
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The number of available cells of interest poses and additional challenge; in some 
applications such as the isolation of CTCs from cancer patient or fetal nucleated red blood 
from maternal circulation, only 1-2 cell are available per milliliter (mL) of whole blood. 
Specificity is problematic for either method, due to the lack of a cell-specific surface 
marker/antibody to exclusively detect CTCs or fetal cells [32].  
Despite great successes, cell sorting techniques are not ideal and therefore remain an active 
area of research. In addition to sensitivity and specificity requirements, an ideal technique 
should not be overly labor intensive, should be automated and quantitative, the results 
should predict clinical outcome, and help the physician personalize therapeutic options. 
Automating sample preparation and handling would minimize human errors. Integration of 
preparation, cell sorting, and post processing will lead to more cost-effective instruments, 
and alleviate the need for trained personnel and infrastructure. Microfluidic technology 
enables the precise control over the cell microenvironment during separation, scales down 
the analyses to very small volume of blood, and has the potential for high-throughput to cell 
separation and analyses. 
2. Microfluidic technology 
2.1. What microfluidic has to offer? 
Microfabrication enables the deposition and etching of thin layers (angstrom to micrometer) 
of different materials on silicon or glass substrates. These layers can be patterned with 
accuracy and high resolution, down to the nanometer level using lithography. Lithography 
is the technique used to transfer a pattern from a mask to the substrate to control the 
location of the deposition of the next layer or the etching of an existing layer on the 
substrate.  
Microfabricated devices have been used in a broad range of biomedical and biological 
applications. In the last decade, microchips have been used in microscale sensors for 
surgical instruments, to monitor physiological activities, in microfluidics applications such 
as drug discovery and delivery, cell sorting, DNA amplification, electrophoresis, etc. Of 
relevance to this chapter are the microchips for blood fractionation and cell sorting.  
Micromachining consists of a series of robust, well controlled, and well characterized 
processes that enable the fabrication of microfluidic devices. Such devices can be made cost-
effective by the use of any of a wide range of biocompatible polymers or plastics and bulk 
processing (mass production). The miniaturization of reactions and assays confers many 
advantages over “macro” scale techniques beyond the obvious reduction in quantities of 
reagents and materials required per test. The scaling down of volumes results in higher 
surface to volume ratio: a cube with side length L will scale down by a factor of L3, while the 
surface area will scale down by only a factor of L2. Thus, miniaturization results in higher 
reactivities, shorter diffusion distances, smaller heat capacities, faster heat exchange, shorter 
assay times, and better overall process control, as well as the capability to integrate multiple 
steps and to achieve massive parallelization on-chip. Additionally, microfluidic devices are 
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safer than “macro” platforms due to the smaller chemical quantities used and hence the 
lower stored energies. A microfluidic device that performs one assay is typically referred to 
as Lab-on-a-chip, while a device that integrates more than one step is referred to as micro 
total analysis system (µTAS) [18]. 
2.2. Introduction to microfabrication 
This section will briefly describe the basic concepts in the microfabrication of microfluidic 
devices. Microfabrication is the already subject of many textbooks and the interested reader 
can consult one of these for more in-depth details [33, 34]. Microfabrication is the technology 
developed by ICs industry to make devices and circuits with feature sizes as small as 14 nm 
in research, and 45 nm in production. Among these are the microprocessors and the 
electronic components found in computers, smart phones, television sets, and major other 
electronic products. Microfabrication is also used for MEMS devices (micro-electro 
mechanical systems), devices that include a movable part and can be used for sensing. The 
airbag sensor used to deploy an airbag in a vehicle, the pressure sensors inside car tires, and 
the electronic compass in a smart phone are all examples of MEMS devices that we 
unknowingly use every day. BioMEMS, microfluidic devices, and µTAS are all 
microfabricated devices similar to MEMS but customized for biological and chemical 
applications.  
Creation of a a new microfluidic device includes design of the channel(s), fluid inlet(s) and 
outlet(s), using a CAD (computer-aided design) software. These softwares, such as 
CoventorWare® [35], ANSYS CFD [36], COMSOL Multiphysics® [37], can be also used for 
simulation of the various design parameters such as device dimensions, heat transfer, and 
flow conditions, therefore narrowing the design space range in which optimum 
performance should be obtained. The pattern of channels is laid out with the CAD software; 
this is the 2D design of the device. The depth of the channel will be determined by the 
etching time. The drawings are transferred to a mask, typically a glass or quartz plate 
(transparent to UV light), covered with chrome. The chrome is etched (removed) where the 
UV light will expose the photoresist. The mask, similar to a stencil, transfers the pattern to 
the photoresist. The device is built on a substrate, which is a silicon, glass or quartz wafer, or 
a regular glass slide. After substrate cleaning, the photoresist, a photosensitive polymer, is 
applied. Photoresist is dispensed onto the substrate and it is spun at high speed (2000-
4000rpm) to create a thin (1-100 micrometer), uniform and smooth layer. The mask is placed 
in contact with the substrate and exposed to UV lights on a mask aligner. The photoresist is 
developed in a developer solution specific for it, and is removed from areas exposed to UV 
light (positive photoresist). The channels can be etched, with substrate material being 
removed from areas unprotected by the photoresist. Etching can be either wet (using 
chemicals) or dry (plasma etching). Deep reactive ion etching (DRIE) is a plasma etching 
technique typically used to achieve deep channels with vertical side walls. Use of DRIE is 
necessary if the etched substrate will serve as a template for molding devices in polymer 
such that the polymer mold can be peeled off the substrate. At this stage, the device can be 
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sealed by the bonding of a top piece to the substrate. Top pieces are typically transparent, to 
permit observation under the microscope. Silicon can be bonded to glass by thermal or 
anodic bonding technique. Usually, however, microfluidic devices are constructed of 
polymer. Polymers are more cost effective, transparent, and biocompatible materials, many 
polymer devices can be molded from one silicon master, this is a key advantage because 
microfluidics devices are hard to clean and hence, can only be used for one or a few 
experiments.  
Polydimethysiloxane (PDMS), PMMA, polyurethane, and polystyrene are all polymeric 
materials used for microfluidic devices. PDMS, the most frequently used, comes in the form 
of two liquid components that are mixed (1:10, w/w) and poured onto the substrate. The 
PDMS is degassed to remove all air bubbles and ensure that the liquid fills the smallest 
feature of the mold. PDMS is cured in a 60-80oC oven for 20 to 45 min to solidify. Once solid, 
it can be peeled off the master substrate. PDMS devices are sealed with glass cover slips to 
form the channels. Several alternatives to the above described processes exist that can 
accelerate fabrication. Masks can be printed on transparencies using high-resolution 
printers; this method is suitable for feature sizes of 100 µm or larger. SU8 is a photoresist 
that is used to create deep structures for molding eliminating the need for deep etching such 
as the utilization of DRIE. Utilization of a chrome mask and a well-equipped clean-room 
facility are necessary for making devices with very small features; sub-micrometer to a few 
micrometers. The development cycle from concept to prototype can take few weeks. For less 
fine featured devices, the use of transparencies, polymers, and/or SU8 can be reduce the cost 
and developmental time to one to few days from concept to prototype [38]. Figure 1a and 1b 
illustrates the typical processes involved in making channels in silicon and molding devices 
in PDMS respectively. 
 
Figure 1. a: Schematic summary of the processes involved in making channel in a hard substaret such 
as silicon. b: Schematic summary of steps involved in making a PDMS mold from a hard master. 
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2.3. Types of flow: laminar versus turbulent  
Two modes of fluid flow exist: laminar and turbulent. In laminar flow, the fluid moves with 
slow velocity and each particle of fluid moves in a straight trajectory parallel to the channel 
walls in the flow direction; and the velocity, pressure, and other flow properties at each 
point in the fluid remain constant. There are no cross-currents perpendicular to the flow 
direction, no eddies or swirls of current in laminar flow. Examples are oil flowing slowly 
through a tube, and blood flowing through a capillary. Turbulent flow in contrast is chaotic, 
with rapid, spatial and temporal variations of pressure and velocity. Examples of turbulent 
flow are the blood flow through in arteries, the flow of water through pumps and turbines, 
and the flow eddying seen in boat wakes and around the wing tips of aircraft [17, 33]. 
The relative turbulence of a flow can be determined by the dimensionless Reynolds number 
(Re), which is the ratio of inertial forces to the viscous forces:  
e
L
R v   
Where: 
 is the density of the fluid (kg/m³), 
V is the mean velocity of the object relative to the fluid (SI units m/s), 
L is a characteristic linear dimension, (travelled length of the fluid, and 
µ is the dynamic viscosity of the fluid (Pa·s or N·s/m² or kg/(m·s)). 
Below a certain Re value the flow is laminar; above this threshold the flow becomes 
turbulent. For macroscopic structures such as pipes with a circular cross-section, the 
transition from laminar to turbulent flow has been empirically determined at Re of 
approximately 2300. For most microstructures, in contrast, the Re number is usually low (10-
1 to 100) thus only laminar flow is relevant for microfluidic devices. 
3. Fluid transport process 
3.1. Poiseuille flow  
A pressure-driven laminar flow inside a tube with a circular cross-section, away from the 
entrance, is commonly known as Hagen-Poiseuille flow or simply Poiseuille flow [17, 33]. This 
flow is governed by the Navier-Stokes equations, which are nonlinear, second-order, partial 
differential equations for describing incompressible fluids. These equations are derived 
from motion and conservation of mass equations. Poiseuille flow is a solution to the Navier-
Stokes equation, and describes the fluid velocity at any point as a function of the viscosity, 
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Where: 
Vz is the velocity distribution, 
µ is the fluid viscosity, 
(p/z) is the z component of the pressure gradient, 
R is the distance from the center of the tube, and 
R is the radius of the tube. 
This equation reveals that the velocity distribution is parabolic, with the maximum velocity 
occurring at the center of the tube. Figure 2a 
3.2. Electrokinetic Flow 
Electrokinetic flow is the underlying basis of electro-osmosis, electrophoresis, streaming 
potential, and dielectrophoresis. In electro-osmosis, fluid is made to flow through, by the 
application of an electric field. The field induces the formation of an electric double layer 
(EDL). This EDL consists of (1) a compact liquid layer adjacent to the channel surface that 
has immobile balancing charges, and (2) a second diffuse liquid layer, composed of mobile 
ions. Most solid-liquid, and many liquid-liquid, interfaces have an electrostatic charge, and 
hence an electric field exists there. In the presence of an electric field, molecules of many 
dielectric materials, such as the glass or polymer used for making the microfluidic devices, 
will become permanently polarized, since the material has a dipole that comprises two 
opposite, but equal, charges, due to the asymmetrical molecular structure. The electrostatic 
charges on the channel surface, mainly negative charges in the case of glass or polymer, 
attract counter-ions from the liquid. This attraction creates the channel double layer; the first 
has immobile charges that balance the charges on the channel surface. The second diffuse 
layer has a higher concentration of counter-ions near the channel surface than does the bulk 
of the fluid. The net charge density gradually decreases to zero in the bulk liquid. The 
diffuse layer will move under the electric field. Surrounding molecules are pulled along by a 
viscous effect, resulting in bulk fluid motion or electro-osmotic flow. The diffuse layer is 
several nm to 1 or even 2 µm thick, depending on the ionic concentration and electrical 
properties of the liquid. The Poisson-Boltzmann equation describes the ion and potential 
distribution in the diffuse layer. The electro-osmotic flow velocity can be quantified by Li’s 
equation [39]: 
av z r oV E
    
Where, 
Vav is the average elelctro-osmotic flow velocity, 
z is the applied electric field (V/m), 
r is the Dielectric constant of the medium, 
o is the permetivity of the vacuum, 
 is the zeta potential at the shear plane, and  
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µ is the Viscosity. 
This equation reveals that the velocity is linearly proportional to the applied electric field, 
such that all travel at the same speed inside the channel Figure 2b. This situation contrasts 
with the pressure-driven flow, in which the middle has the greatest velocity resulting, in a 
parabolic migration.  
In conclusion, the velocity distribution being parabolic or flat can impact the microfluidic 
device performance. The electrokinetic flow is favored in applications such as DNA 
separation, proteomics, rapid mixing, and time dependent applications where sample 
homogeneity and reaction time need to be stringently controlled. The flow pattern is 
typically not an issue for cell separation since it happens in continuous flow without time 
dependence.  
 
Figure 2. a: schematic of velocity distribution in Poiseuille flow. 
b: schematic of velocity distribution in Electro-osmosis flow. 
4. Technologies and on-chip mechanisms of separation 
Cells are separated either in bulk or individually. In individual cell sorting, each cell is 
analyzed, and then the cells of choice are individually selected. This technique is rarely 
used, due to its very low throughput. Thus cells are generally sorted by bulk separation, in 
which a large number of cells are selected on the basis of shared characteristics such size, 
density, or the affinity of a receptor for a specific cell-surface target. The result of such bulk 
separation is enrichment rather than a true purified population [9].  
The cells of interest are first identified, than separated, and finally collected. The initial step 
is to screen the cells of interest to identify one or more common specific characteristics to be 
used as the basis of sorting. Specific characteristics can be intrinsic such as size, density, 
response to electrical or magnetic fields, or resistance to chemical lysis. Alternatively, cells 
can be labeled using a specific cell surface target that binds to a monoclonal antibody 
conjugated to a fluorophore, or to magnetic particles for flow cytometric cell sorting.  
Once the cells of interest have been identified, they can be separated from the other cell 
types. In some methods, the identification and separation occur simultaneously, e.g., affinity 
capture.  
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In other methods such as fluorescence-activated cell sorting, cells are identified on the basis 
of the presence or absence of one or more fluorescent tags then are then sorted into two or 
more separate containers. Sorting can either use negative or positive selection. In positive 
selection, the target cell itself is labeled; in negative selection, it is the background cells or 
other cells in the solution that are labeled.  
4.1. Separation of cells on the basis of affinity  
Affinity chromatography or separation of cells on the basis of their affinity is the 
fractionation of a cell mixture based on the use of specific immunologic targets. One or more 
of these specific targets are immobilized on a chip surface; there, they capture the cells of 
interest with high purity (positive selection), or alternatively they capture large number of 
background cells so as to enrich the remaining sample (negative selection). Microfluidic 
devices provide a high surface area to volume ratio, which is necessary for chromatography; 
to keep processing times manageable, many devices can be used in parallel. 
Toner’s group demonstrated affinity-based separation of cells based on two specific 
immunologic targets; CD5 and CD19 [40]. Two microfluidic devices were used for affinity 
separation: a Hele-Shaw device and a parallel flow chamber device. The chamber in the Hele-
Shaw device was 57 µm deep and 50 mm long, and the inlet was 5 mm wide. The device was 
fabricated using PDMS and sealed with a glass cover slip. The chip surface was treated with 
silane solution in ethanol, followed by GMBS in ethanol (a water-soluble amine-to-
sulfhydryl crosslinker with a short spacer arm), flushed by Neutravidin (strong affinity to 
biotin) solution in PBS, and incubated overnight. Antibody, anti-CD5 or anti-CD19, solution 
stocks were diluted in BSA and sodium azide, flowed through the chamber, incubated for 15 
min and then flushed with PBS to remove unattached antibodies. Flow experiments were 
performed with human immature T-lymphoblasts (MOLT-3 cells) and human mature B-
lymphocyte (Raji cells). MOLT3 cells, which express CD5 but not CD19, were stained with 
green cell-tracker dye. Raji cells, which express CD19 but not CD5, were stained with orange 
cell-tracker dye. Cells were flowed over the coated chip surface with a syringe pump, at 
flow rate of 30 or 50 µL/min. Flow rates were optimized for efficient capture to allow 
dynamic cell adhesion, shear stress was minimized in the axial direction permitting 
sufficient interaction between the cell and the coated surface so that binding can occur. A 
device coated with anti-CD19 was used to deplete a 50:50 MOLT-3/Raji cell mixture of Raji 
cells, producing a 100% pure MOLT-3 in less than 3 minutes. Obviously, this level of 
enrichment is exceptional and cannot be achieved with a heterogeneous (“real world”) 
blood sample. Nevertheless enrichment by 10- to 2000-fold have been obtained using similar 
devices [41]. Sin and coworkers also used an alternative parallel flow serpentine chamber 
design, the effective increase in device length was intended to increase the number of cell 
capture and also to ensure constant shear stress throughout the device. In summary, Sin and 
coworkers have demonstrated the possibility of using dynamic cell attachment to antibody-
coated microfluidic chambers in shear flow to enrich mixtures of MOLT-3 and Raji cells. 
To further increase the chip surface area, Toner’s group has developed a microfluidic platform 
“the ‘CTC-chip” [42]. This device is composed of a two-dimensional array of round pillars. 
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These pillars are 100 µm in diameter and 100 µm deep; they are separated by 50 µm and each 
three rows are shifted from the previous three rows by 50 µm to maximize interaction (Figure 
3). The chip was etched in silicon with DRIE to produce smooth straight pillars; the result was 
78,000 pillars within a surface of 970mm2. The pillars were coated with antibody (EpCAM). 
The chip is enclosed by a manifold. The group had optimized the flow rate allowing adequate 
cell-pillar interaction time, and to minimize shear forces, ensuring attachment of maximal 
number of cells to the pillars. The chip successfully identified CTCs in the peripheral blood of 
patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 (99%), 
with a range of 5–1,281 CTCs per mL and approximately 50% purity (Figure 3). 
Similarly, Chang and coworkers produced two chips with an array of pillars coated with E-
selectin IgG chimera, to test the interaction of HL-60 and U-937 cells with these structures 
[43]. In one device, the square pillars were separated by 25 µm; each pillar was 25 µm wide 
by 25 µm long by 40 µm deep. In the second device, pillars were 10 µm wide by 35 µm long 
by 40 µm deep, and spaced 30 µm apart. In this second device each row of pillars was offset 
from the previous one by 15 µm so as to allow more cells to ne interrogated. Devices were 
fabricated in silicon by DRIE and were sealed with thin pyrex glass using anodic bonding. 
In the first device, HL-60 cells were enriched 400 fold over to the original concentration, 
while the second device achieved only 260-fold enrichment. Offsetting the pillars on the 
second device had been expected to improve the cell capture, however smaller size resulted 
in the flow being faster in the channels, thereby increasing shear stress on the cells and 
making them less likely to be captured on the surface. 
It is possible to further increase cell surface interaction if the cells passed through a packed 
bed of antibody-conjugated beads. However, such a design is no longer attractive since cell 
crossing takes as long as 2 hr due to the retardation of the flow rate [44].  
 
Figure 3. Isolation of CTCs from whole blood using a microfluidic device a, The workstation setup for 
CTC separation. The sample is continually mixed on a rocker, and pumped through the chip using a 
pneumatic-pressure-regulated pump. b, The CTC-chip with microposts etched in silicon. c, Whole 
blood flowing through the microfluidic device.d, Scanning electron microscope image of a captured 
NCI-H1650 lung cancer cell spiked into blood (pseudo coloured red). The inset shows a high 
magnification view of the cell (Reprinted with permission from Nature Publishing Group). 
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Malmstadt and coworkers developed an innovative approach that could benefit from the 
increased bed of beads area while avoiding its limitation [45]. The group used beads that 
were modified twice: (i) with the affinity moiety biotin, which binds streptavidin to function 
as chromatographic affinity separation matrix, (ii) with the temperature-sensitive polymer 
poly(N-isopropylacrylamide). At room temperature, a suspension of these beads flows 
through the channel. When the temperature is raised above a certain threshold, the beads 
aggregate. The sample is then introduced and the beads remain stable during sample flow, 
and the device functions as a chromatography affinity matrix. The temperature is then 
lowered below the threshold to allow the beads to dissolve and elute from the channel. 
4.2. Separation of cells by flow cytometry 
Flow cytometry is a technique that uses light scattering to measure various physicochemical 
characteristics of suspended cells. Cells are stained and then confined to flow in a single file 
through a fluidic system. The stream of cells passes at high speed through a focused laser 
beam. Light scattering and fluorescence data are collected from the individual cells and 
analyzed. A laser of one wavelength such as blue can be used for excitation; the instrument 
records fluorescence at multiple wavelengths such as red, orange, and green, in addition to 
the blue light scattering in the forward direction and right angle to the laser beam. This 
information is processed by a computer attached to the cell analytical instrumentation. 
Alternatively, flow cytometers can be equipped to sort cells of interest based on scattering 
properties, by use of an electric field, flow switching, or optical trapping.  
The first key aspect of flow cytometry is the focusing of the cells in a single file so they can 
be individually interrogated by the optical detection system. This step is usually achieved 
by hydrodynamic focusing [46, 47]. A sheath flow surrounds the samples from both sides; 
the flow rate can be adjusted to make the middle stream as thin as required to carry cells in a 
single file (Figure 4). This also reduces cellular aggregation that can clog the device. 
Microfabricated channel structures are capable of stably delivering samples to a detection 
area with higher accuracy and better flow control than are glass capillary-based fluidic 
systems used in conventional flow cytometric equipment; this superior performance is a 
function of the small channel dimensions possible in microfluidics. The hydrodynamic 
focusing typically constrains the cells on both sides, but not in the z direction [48].  
Miyake and coworkers have developed a multilayered sheath flow chamber that can 
generate a three-dimensionally focused narrow stream. The channel system was formed by 
the lamination of five separate silicon and glass plates; defining the three-dimensional 
geometry of a sample injection nozzle and a detection microchannel. A simpler, albeit less 
flexible or programmable, approach would be to use a shallow channel that confined the 
cells in the z direction to remain within the analysis window [49].  
Sheath liquid-based hydrodynamic focusing, while being the standard technology in 
microfabricated flow cytometers, require continuous pumping of a large volume of sheath 
liquid at a high flow rate to pinch the middle stream down to single-cell width. Sheath 
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liquid volume required can be up to 1000 time the sample volume. New types of 
microfluidic systems have been developed to minimize or eliminate the sheath liquid 
requirements and to further miniaturize flow cytometry. Huh and coworkers demonstrated 
the use of ambient air as an alternative sheath fluid in a disposable air–liquid two-phase 
microfluidic system [50]. The system produces a thin (>100 μm) liquid stream transporting 
cells focused by air-sheath flows in a rectangular microfluidic channel. To achieve this 
focusing, the authors had to conduct a detailed study of the PDMS surface wettability, and 
of the flow conditions so as to overcome the two-phase (air-liquid) instabilities.  
In a contrasting approach, a V-shaped groove device was developed by Altendorf and 
coworkers to transport blood cells in a single file. The groove microchannel was fabricated 
by anisotropic wet etching of silicon [51]. The top of the groove was 20–25 μm, wide and the 
constriction channel geometry allowed the generation of a single-file stream of blood cells 
moving through the channel without the need for sheath fluid. Light scattering caused by 
the flow of the individual blood cell through the device was measured by optics based on a 
photomultiplier tube, photodiode detector, and laser source. The device was capable of 
differentiating between various cell populations such as RBCs, platelets, lymphocytes, 
monocytes and granulocytes, based on the intensity of scattering signals. This study 
demonstrated the potential utility of such a device for differential counting of blood cells. 
The second aspect of a flow sorter system that is pertinent to our discussion is the system 
capability to sort cells at high speed. The requirement of rapid deflection after the cell has 
been identified by the optical system, can be achieved through redirection of the flow via 
high-speed valving or reverse electrokinetic flow, dielectrophoresis, ultrasonic transducer, 
or optical trapping.  
Kruger and coworkers achieved switching by use of pressure-driven flow systems [46]. As a 
liquid sample stream that was hydrodynamically focused along the center of an input 
channel approach a junction, a small amount of buffer liquid is injected into or withdrawn 
from the side stream along a switch channel, causing the focused sample stream to be 
deflected and to flow into a collection channel.  
Fu and coworkers demonstrated the use of electric field to quickly switch the flow from the 
waste to the collection channel, to isolate a cell of interest [52]. The disposable activated cell 
sorter consisted of three channels joined at a T shaped junction. Electro-osmotic flow drives 
cells or particles from the inlet to the junction where the flow is diverted to the waste or 
collection channels. The diversion is achieved by a switching of the electric field at the T 
junction to control the flow in a rapid manner. This device does not use sheath flow but 
rather a small-diameter channel, to constrain the cells in single file. When the fluorescently 
tagged bacterial cell of interest is detected, the sample stream flowing from an inlet to a 
waste port is quickly switched by reversed electric field, such that the flow is diverted 
direction to a collection port, selectively delivering the labeled target particles to a sample 
collector. Using this fluidic switching-based sorting technique, the authors demonstrated 
sorting of fluorescent microbeads and E. coli cells at a throughput of ∼10 beads s−1 and ∼20 
cells s−1. The device was fabricated by softlithography in PDMS. 
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Similarly, Oakey and coworkers demonstrated the use of electric field for diverting the flow 
rather than switching since their device did not have hydrodynamic focusing [53].  
Johansson and coworkers developed an ultrasound transducer that was placed in the 
middle of the channels at the intersection between the waste and collection channels. In the 
absence of ultrasound wave, cells migrated to the waste channel. When a cell of interest was 
identified, the transducer produced a radiation force acting on a density interface that 
caused fluidic movement, and the particles or cells on either side of the fluid interface were 
displaced in a direction perpendicular to the standing wave direction toward the collection 
channel [54]. 
Chun and coworkers demonstrated a polyelectrolytic salt bridge-based electrode, placed 
across the channel to replace the laser used for cell fluorescence analyses. The salt bridge 
produced impedance signals in proportional to cell’s size to be used as basis for sorting to 
eliminate the need for the optical system that typically exist off-chip [55]. 
 
Figure 4. Left: Image of prototype device in operation. Right: Computational modelling of fluid 
dynamics in a microfluidic cell sorter structure. The performance of this structure was simulated using 
FlumeCAD (Microcosm Technologies), a finite element modelling (FEM) software package that uses full 
Navier–Stokes equations. (Printed with permission from Institute of Physics Publishing). 
4.3. Separation of cells using immunologic targets  
Magnetic separation can be achieved by using the cell’s intrinsic magnetic properties or by 
attachment of a magnetic particle to a specific surface antigen that can later be exposed to a 
magnetic column for separation. Magnetic particles are typically composed of large 
numbers of superparamagnetic nanoparticles packed inside micrometer sized sphere made 
of polymer. The surface of each magnetic bead is then functionalized with antibody specific 
to an antigen found on the surface of one type of cell. The cells are incubated with the 
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magnetic beads to allow interaction; the magnetic bead attaches specifically to the cell by the 
antibody-antigen recognition. The cells are transferred to the magnetic column of a 
separation device. The cells are then manipulated via a magnetic field generated by an 
internal patterned electromagnet or external macroscopic magnets. The cells attached to the 
magnetic beads stay on the column, while other cells, not expressing the antigen, and hence 
not attached to beads, flow through it. With this method, the cells can be separated 
positively or negatively with respect to the particular antigen(s). Positive selection results in 
the binding of the cells of interest to the column and they then need to be washed off of the 
column. In negative selection, the cell of interest do not bind, and are passed through the 
column enriched [56].  
Han and coworkers have exploited the intrinsic differences in the magnetic properties of 
the RBCs and WBCs without use of magnetic beads, to separate the cell types in a one-
stage or three-stage magnetophoretic microseparator [57]. Their single-stage device was 
able to separate 91% of RBCs out of whole blood; the three-stage device improved on this 
performance to separate 93.5% of RBCs and 97.4% of WBCs from the whole sample at 5 
µL/hr flow rate. Qu and coworkers demonstrated identical separation efficiency [58]. 
Han’s channels were 50 µm deep created by hydrofluoric acid etching of borofloat glass 
slides. The wire area, included to deform the magnetic field inside the channel and hence 
generated a high field gradient, was defined using photolithography, and a Ti/Cu/Cr 
seed layer was deposited by e-beam evaporation, followed by microelectroforming (a 
process for making thick metal structure) of the ferromagnetic nickel wire. The device 
was sealed with a second glass slide bythermal bonding. An external magnet provided 
the magnetic field. 
Adams and coworkers developed a multi-target magnetic cell sorter to purify two types of 
target cells. They simultaneously sorted (i) multiple magnetic tags achieving >90% purity 
and >5,000-fold enrichment, and (ii) multiple bacterial cell types achieving >90% purity and 
>500-fold enrichment, with a throughput of 109 cells per hour [59]. Their device incorporates 
microfabricated ferromagnetic strips (MFS) to generate large and reproducible magnetic 
field gradients within its microchannel and utilizes a multistream laminar flow architecture 
to accurately control the hydrodynamic forces. This design enables continuous sorting to of 
multiple target cells into independent spatially addressable outlets with high purity and 
throughput. 
The chip was fabricated in three layers: glass-PDMS-glass. The channel was 50 µm deep and 
500 µm wide, and contained two sets of 20-200 nm thick nickel patterns that compose the 
MFS structures. (Figure 5) The two sets of MFS arrays are aligned at different angles with 
respect to the flow direction. The result is that two magnetophoretic forces that differ is 
amplitude and direction, act on the labeled cells. The labels are different in size and 
magnetization and thus require different forces to deflect them out of the stream of laminar 
flow. The magnetic field is created with a magnet made of a custom stack of neodymium-
iron-boron (NeFeB) and placed underneath the chip.The MT-MACS sorting chip was used 
to sort two subtypes of Escherichia coli MC1061 cells. One type was labeled with label 1 with 
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tag 1 (r = 2.25 µm, M =14 kA/m) and tag 2 (r =1.4µm, M = 30 kA/m), and was fluorescently 
labeled for observation under a fluorescent microscope. Using 5 mL/hr flow rate, each of the 
tags was enriched several thousand fold at its respective outlet after a single round of 
purification. At outlet 1, the population with tag 1 was enriched from 0.020% to 95.876% of 
the total population corresponding to a 5,000-fold enrichment. The impurities in this fraction 
consisted of 2.974% tag 2 and 1.150% nontarget beads. Similarly, the population with tag 2 
in outlet 2 was enriched 15,000-fold, with contamination of 3.125% target 1 and 6.358% 
nontarget beads. The waste output consisted almost entirely of nontarget beads (99.997%), 
and contamination of 0.002% of tag 1 and 0.001% of tag 2. 
 
Figure 5. MT-MACS separation architecture. (A) (Step A) The sample contains an excess of nontarget 
cells and 2 different target cells (target 1 and target 2) that are labeled with 2 different magnetic tags (tag 
1 and tag 2) by specific surface markers. (Step B) The sample is continuously pumped into the device 
where the 2 target cell types are sorted into spatially-segregated independent outlets. Separation occurs 
in 2 regions of high magnetic field gradient generated by the microfabricated ferromagnetic strip (MFS) 
1 and MFS 2. (Step C) After sorting, the eluted fractions from each outlet are analyzed via flow 
cytometry. (B) A free-body diagram showing the balance of forces at the MFS structures. At MFS 1 (_1 _ 
15°), tag 1-labeled target 1 cells are deflected and elute through outlet 
1 because Fm1 _ Fd1 sin(_1). This is not the case for tag 2-labeled target 2 cells, which are instead 
deflected at MFS 2 (_2 _ 5°) because Fm2 _ Fd2 sin(_2), and elute through outlet 2. Nontarget cells are 
not deflected by either MFS and elute through the waste outlet. (C) Optical micrographs (magnification 
_ 100_) of the tags being separated at the 2 MFS structures at a total flow rate of 47 mL/h (sample _ 5 
mL/h, buffer _ 42 mL/h). (Left) Tag 1 is deflected by the steep angled MFS 1. (Right) Tag 2 is deflected by 
MFS 2 (Reprinted with permission from PNAS). 
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Xia, Modak and coworkers used similar have demonstrated similar magnetic cells sorting 
design with the structure concentrating the magnetic field being adjacent to the flow 
channel but not exposed to the sample solution [60, 61].  
Lee and coworkers demonstrated the use of patterned channels to magnetically manipulate 
single cell. Lee’s device had a matrix of two separate layers of straight gold wires, each 
addressed independently, aligned perpendicular to each other, and covered with an 
insulating layer. A magnetic field was created by passing electrical current through the 
wires creating a programmable magnetic field to control the motion of individual cells in the 
fluid. Lee’s device demonstrated the separation of viable from nonviable yeast cells attached 
to magnetic beads [62]. 
Saliba and coworkers demonstrated a 2D array of dots by deposited by microcontact 
printing of a magnetic ink acting as magnetic traps. Antibody-coated magnetic beads were 
injected in the channels and were submitted to a Brownian motion in the absence of any 
field. The application of an external vertical magnetic field induced the antibody-coated 
magnetic beads to assemble on the patterned dots creating columns [63]. 
Kose and coworkers demonstrated a novel device to use colloidal suspension of 
nonfunctionalized magnetic nanoparticles for manipulation and separation of 
microparticles. It is a size-based separation mediated by angular momentum transfer 
from magnetically excited ferrofluid particles to microparticles. The nanocytometer is 
capable of rapidly sorting and focusing two or more species, with up to 99% separation 
efficiency [64].  
4.4. Separation of cells using chemotaxis phenomena 
Chemotaxis is the process whereby a single cell, or multicellular organism, moves away or 
toward a certain chemical. This movement can be away from a poison (chemorepellent or 
negative chemotaxis) or toward food (chemoattractant or positive chemotaxis). For example, 
neutrophils leave the blood vessel and migrate toward the smell produced by bacteria in a 
cut of the skin in an effort to defend the body against infection. The influence of these 
gradients of molecules and cues cellular behavior in the surrounding microenvironment is 
an important biomedical focus of study. Chemotaxis, in particular, plays an important role 
in many biological and physiological processes such as creation of new tissues, wound 
healing, cancer metastasis, and embryogenesis. 
To test a cell response to a certain chemical gradient, the cells are typically placed in a well, 
and the test substance or chemical is placed in a second well. The two wells are separated by 
a barrier such as a weir structure (Dunn chamber) or a filter (Boyden chamber), to ensure that 
the cell movement is due only to the signaling only and not random motion or diffusion.  
The development of microfluidic devices for chemotaxis assays was motivated by the need 
to produce the gradient in a controllable and reproducible manner, and to minimize the 
quantities of test substance and cells required per assay [65].  
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Abboodi and coworkers have developed a hydrogel-based microfluidic chip for chemotaxis 
studies [66]. The device consists of three chambers in this study, the middle chamber is filled 
with a 3D porous hydrogel structure that contains the cell culture; here fibrosarcoma cell 
line HT1080 was used as an invasive cancer cell model. First, the left-hand chamber was 
filled with a cellulose enzyme solution and the right-hand one was filled with cell culture 
medium containing fetal bovine serum (FBS) (Figure 6). The cellulose enzyme solution 
diffuses into the hydrogel and degrades it, creating large pores in the structure closer to the 
left-hand reservoir. Pore size is progressively smaller as the solution migrates toward the 
right-hand reservoir. The result is that the cells, stained for observation by fluorescence 
microscopy, moved toward the large pores adjacent to the left-hand reservoir. After 3 days, 
the FBS –containing medium-FBS in the right-hand reservoir was replaced with pure FBS 
i.e., full strength chemoattractant. The cellulose enzyme solution in the left-hand reservoir 
was also replaced with a FBS-containing medium. In response, the cells reversed their 
motion and moved toward the right-hand reservoir containing the pure FBS, confirming 
that FBS is a chemoattractant for this cell type. The negative structure of the chambers of this 
device was fabricated with a 3D printer and a UV-curable polymer. The device was molded 
in PDMS from the polymer structure and sealed with a glass slide. 
Agrawal and coworkers, in an effort to explore the sepsis complications that occur in burn 
patients, presumably as the result of improper activation of neutrophils, developed an assay 
on an advanced switching gradient device for monitoring the migration behavior of these 
cells following thermal injuries [67]. The device (i) integrates the isolation of neutrophils 
from whole blood, (ii) the provision of a controlled combinatorial chemotactic environment, 
and (iii) the monitoring of real-time migration of the captured neutrophils over different 
substrates all on-chip, thereby eliminating the need for preprocessing of the blood. The 
device was made with PDMS and was fabricated with standardized soft lithographic 
techniques. In a first trial, the capture was performed by a coating of the microfluidic cell 
chambers with P-selectin, E-selectin, or fibronectin substrate. A 10 µL drop of blood/heparin 
solution was loaded in the cell-capture device, and the cells were allowed to settle for 10 
min; then flow was initiated (0.5 µL/min) and most of the unwanted cell population was 
washed away. In experiments repeated in the migration device, captured cells were exposed 
to a linear chemotactic gradient of the chemokines IL8 and fMLP. Migration patterns for 
both chemokines over each substrate were recorded with time lapse microscopy and were 
then compared. 
The two chemoattractants, IL8 and FMLP, were used to create a gradient across each 
binding substrate. Neutrophils over P-selectin reacted similarly for the IL8 and fMLP 
gradients. However, for E-selectin, average ‘y’ displacements of 50 µm and 70 µm were 
observed within 30 min in the gradients of fMLP and IL8 respectively.  
For fibronectin, the difference in migration was more significant: the cells migrated about 65 
µm in fMLP gradient, but only 35 µm in the IL8 gradient over similar time courses. This 
system offers an efficient approach to the development of a simple diagnostic tool suitable 
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for a variety of applications in addition to chemotactic studies such as genomic and 
proteomic analyses. 
Chen and coworkers demonstrated a cell migration chip which can monitor chemotaxis at 
single cell resolution [68]. The chip is composed of weirs that captured individual cells. 
Once a cell is captured, the hydrodynamic force will push other cells to the next weir 
through a serpentine channel. A high capture rate over 94% is achieved by optimizing the 
geometry of capture sites and the length of serpentine structures. After capturing, cell 
migration experiments induced by chemotaxis were carried out using the fabricated 
platform, and the behavior of each single cell was successfully traced. 
Englert, Walker, and coworkers focused their effort on generating reproducible gradients 
[69, 70]. Engelrt and coworkers device created reproducible chemoeffector gradients. Two 
gradients, to simulate competing conditions in nature, were created using a Laminar flow-
based diffusive mixing and were tested on Escherichia coli. The sample containing the 
fluorescently stained Escherichia coli, for observation by microscopy, was introduced in a 
middle channel. Two side channels introduced the two gradients: quorum-sensing molecule 
autoinducer-2 (AI-2) and stationary-phase signal indole were introduced, one on each side 
of the sample. Results showed that the Escherichia coli was attracted by the AI-2 and 
repelled by the stationary-phase signal indole. 
 
Figure 6. (A) Schematic for the device. (B) Image for each region in the main storage. (C) Average 
fluorescent intensity of FITC- BSA at four regions from left to right through the porous hydrogel in the 
main storage ± SD (Reprinted with permission from SPIE and A. Al Abboodi). 
4.5. Separation of cells using optical methods and light traping 
Optofluidics technology, which is the mating of optical trapping, switching, and 
microfluidic has been recently introduced as a new manipulation scheme. It has been 
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motivated by its high selectivity, ability to maintain sterility, and how it allowed 
programmable manipulation of particles or fluids in microenvironments based on optically 
induced electrokinetics. While optical switching is often used with flow cytometry as the 
switching or sorting mechanism, it is here presented in a separate section to demonstrate its 
unique capabilities and potential. Typically, a focused laser beam provides a force to hold or 
move a microscopic dielectric particle. The dielectric particle is attracted to the strong 
electric field gradient at the narrowest point of the focused beam. This force is small, in the 
order of piconewtons, depending on the refractive index mismatch, and can be attractive or 
repulsive.  
MacDonald and coworkers introduced a bow-tie like chip with four reservoirs linked in the 
middle by a flow channel (Figure 7). The two reservoirs on one side are for buffer (top) and 
sample (bottom) respectively. The two reservoirs on the other side are for waste (top) and 
sample collection (bottom). In the absence of any force, the cells migrated from their 
reservoir to waste, while the buffer passed to the collection reservoir. The two flows shared 
the channel but no mixing due to laminar conditions. When optical forces were focused on 
the flow of mixed particles as it passed through the lattice, selected particles were strongly 
deflected from their original trajectories into the collection reservoir, while others passed 
straight through, depending upon their sensitivity to the optical potential. The interaction 
with optical fields provided a selective means of removing material matching specific 
criteria from an otherwise laminar stream. The optical force was applied by the mean of a 
five-beam interference pattern created by a 1,070-nm laser beam that passed through a 
diffractive beam splitter, producing four beams diverging from the central, non-diffracted , 
in a cross shape. Collimating optics provided a parameter space to independently control 
the phase and amplitude of each of the five beams before being co-focused through an 
aspheric lens to produce a large, three-dimensional optical lattice through multibeam 
interference [71]. 
Kovac and coworkers introduced a microwell array that is passively loaded with 
mammalian cells via sedimentation. These cells were inspected using microscopy. After 
inspection, cells of interest were levitated from the well using a focused infrared laser into a 
passing stream to the collection reservoir. This is a simple device made of PDMS for the 
channels and the wells were sealed with glass slide [72].  
Shirasaki and coworkers used optics to control a thermoreversible gelation polymer (TGP) 
as a switching valve. The chip has Y-shaped microchannels with one inlet and two outlets. 
The sample containing fluorescently labeled cells was mixed with a solution containing the 
thermoreversible sol-gel polymer. The fluorescently labeled target cells were introduced in 
the channels and observed using fluorescence microscopy. In the absence of a fluorescence 
signal, the collection channel was plugged through laser irradiation of the TGP and the 
specimens were directed to the waste channel. Upon detection of a fluorescence signal from 
the target cells, the laser beam was then used to plug the waste channel, allowing the 
fluorescent cells to be channeled into the collection reservoir. The response time of the sol-
gel transformation was 3 ms, and a flow switching time of 120 ms was achieved. The TGP 
did not affect cell viability [73].  
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Lin and coworkers have demonstrated a microfluidic system based on a computer 
controlled digital image processing (DIP) technique and optical tweezers for automatic cell 
recognition and sorting in a continuous flow environment. In this system, the cells are 
focused electrokinetically into a narrow sample stream and are introduced into the channel 
where they are recognized and traced in real time. Synchronized control signals generated 
by the DIP system are then used to actuate a focused IR laser beam to displace the target 
cells from the main sample stream into a neighboring sheath flow, which carries them to a 
downstream collection [74].  
In summary, Optoelectrofluidic technology, which has been recently introduced as a new 
manipulation scheme, allows programmable manipulation of particles or fluids in 
microenvironments based on optically induced electrokinetics. The behavior of particles or 
fluids can be controlled by inducing or perturbing electric fields on demand in an optical 
manner, which includes photochemical, photoconductive, and photothermal effects [75, 76]. 
 
Figure 7. The concept of optical fractionation. Low Reynolds number flows will be laminar: without an 
actuator all particles from chamber B would flow into chamber D. Chamber A would typically 
introduce a ‘blank’ flow stream, although this could be any stream into which the selected particles are 
to be introduced. By introducing a three-dimensional optical lattice—in this case a body-centred 
tetragonal (b.c.t.) lattice—into the fractionation chamber (FC), one species of particle is selectively 
pushed into the upper flow field. The reconfigurability of the optical lattice allows for dynamic 
updating of selection criteria. For weakly segregated species, the analyte can be either recirculated 
through the optical lattice or directed through cascaded separation chambers. This latter option also 
allows the use of multiple selection criteria in a single integrated chip. The flow volume in our current 
sample cells is 100 mm thick; scale bar, 40 mm (Reprinted with permission from Nature Publishing 
Group). 
4.6. Separation of cells using electrophoresis and dielectrophoresis 
Dielectrophoresis (DEP), first described by Pohl in 1951, is a phenomenon in which a force is 
exerted on a dielectric (insulator that can be polarized) particle when subjected to a non-
uniform electric field. This can take place in either direct (DC) or alternating (AC) electric 
fields. The strength of the force depends on the frequency of the electric field, the medium 
and particle electrical properties, and the particles size and shape. Varying the field’s 
frequency can manipulate particles with different sizes with great selectivity, which is used 
for manipulating cells and nanoparticles.  
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Pommer and coworkers have used DEP phenomenon to separate platelets directly from 
diluted whole blood in microfluidic channels. Since platelets are the smallest cell type in 
blood, DEP-activated cell sorter (DACS) was used to perform size based fractionation of 
blood samples and continuously enrich the platelets [77].  
Hu and coworkers used a comparable device to Pommer, but the difference in size-based 
separation was attributed to the size of the antibody-conjugated beads attached to the target 
instead of the cell’s intrinsic size [78]. Pommer’s device is composed of two identical 
purification stages, in each stage a buffer is introduced in the middle of the channel while 
the sample is loaded from both sides. The channel electrodes are at angle with the flow 
forming a funnel shape where the sample flows from the wide to the narrow side. The force 
exerted by the electric field on the cells has a cubic dependence on the radius (R3) and can 
be controlled by varying the applied voltage. The hydrodynamic drag force under laminar 
flow has a linear dependence on the particle radius (R1) and is controlled by varying the 
flow rate. Therefore, the resulting forces exerted on the cells has a square dependence (R2) 
and is used to deflect large cells (RBCs and WBCs) into the middle buffer stream to the 
waste collection reservoir while the platelets remain in the side flow and migrate to the 
collection reservoir. Post sorting cytometric analysis revealed that a single pass through the 
two-stage device yields 95% purity of platelets with minimal platelet activation. Two 
Borosilicate glass wafers were used to fabricate the top and the bottom of the device, the 
titanium-gold (20nm and 200nm respectively) electrodes were patterned and evaporated 
using e-beam, a polyimide layer was spun and patterned to form 20µm channel depth 
between the top and bottom wafer. The two wafers were aligned and bonded using thermal 
bonding (300oC) then 375oC to cure the ployimide. 
Vahey et al have extended DEP to multiple electrodes creating an electric conductivity 
gradient to separate cells and particles. This is similar to using isoelectric focusing in 
analytical chemistry and proteomics with the conductivity replacing the pH gradient. Vahey 
et al have used this device to achieve label-free separation of multiple (>2) subpopulations 
from a heterogeneous background. The channel was 1mm wide and 20 µm deep molded in 
PDMS and sealed with pyrex wafer that has the evaporated electrodes. The six electrodes, 
200nm gold on top of 10nm titanium (adhesion layer) are 60µm wide, separated by 15 µm, 
and are patterned at an angle with the flow direction. The electrical gradient was used to 
separate 1.6, 1.75, and 1.9 µm polystyrene beads from a mixture. Additionally the device 
was successfully used to separate similar size beads based on surface conductance due to 
different coating such as COOH modified and unmodified, as well as sorting nonviable 
from viable cells of the budding yeast Saccharomyces cerevisiae [79]. 
Lapizco-Encinas et al have used insulator-based (electrodeless) dielectrophoresis (iDEP), in 
which the nonuniform electric field needed to drive DEP is produced by insulators, 
avoiding problems associated with the use of electrodes [80]. This channel was 10.2mm long 
and contained a two dimensional array of 10µm deep pillars etched in borosilicate glass. 
The channel was thermally bonded with a drilled cover plate for fluid access. Two platinum 
wires, the only electrodes in the device, were placed in the inlet and outlet reservoirs, 
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producing mean electric fields of up to 200 V/mm across the insulators. The insulator posts 
disturbed the electric field lines, squeezing them between the pillars. This created higher 
field strength between the pillars. Cell trapping and release were controlled by modifying 
the relative responses of electrokinetics and DEP by adjusting the magnitude of the applied 
voltage. Dead cells had significantly lower dielectrophoretic mobility than live cells but 
similar electrokinetic mobilities. Therefore, live cells were concentrated between the pillars. 
Cells were labeled with Syto 9 and propidium iodide for observation through a fluorescent 
microscope (Figure 8). 
 
Figure 8. Schematic representation of the experimental setup: (a) top view, showing the manifold, glass 
chip, an enlargement of the flow microchannels; (b) cartoon showing the electric field lines being 
squeezed between the insulating posts; (c) side view showing the manifold and glass chip on the 
microscope stage (Reprinted with permission from ACS Publications). 
4.7. Separation of cells by size 
Size-based sorting has been our work’s focus for a few years; we have successfully 
demonstrated the separation of WBCs, RBCs, or circulating tumor cells from whole blood, 
and fetal nucleated red blood cells (fNRBCs) from cord blood. Size- and density-based 
sorting has been demonstrated in open flow channels by Seki’s group using “pinched flow 
fractionation” [81]. Enrichments up to 20 fold have been accomplished by the chip shown in 
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Figure 9. The sample is loaded into the 20 µm wide open channel, and a second solution, a 
buffer, is loaded from a second channel that is 200 µm wide. The buffer pinches the flow 
width against the channel wall down to 15 µm, forcing the cells to align along the channel 
wall, before the channel opens to a 350 µm wide area with 12 outlet ports. The separation 
occurs in the wider channel; the smaller, lower-density cells segregate and are dragged 
along the channel wall, while the larger, denser cells, tended to sediment earlier in the 
pinched region and occupy the outer stream that empties to a different outlet port. The 
device was fabricated by standard photolithographic techniques and was molded in PDMS, 
from an SU8 master. Wilding’s group used weir-like structure to create a 3.5 µm space 
between the silicon bottom and a glass top of a device to separate WBCs from whole blood, 
they could then use the cell’s DNA for amplification [82-84].  
Austin’s group has demonstrated cell sorting based on asymmetric bifurcation of a laminar 
flow around a periodic array of micrometer-scale pillars [85, 86]. Each row of pillars is offset 
horizontally with respect to the previous row by a fraction of the distance separating the 
pillars. This offset between successive rows forces particles to navigate around the obstacles 
and induces a lateral displacement proportional to their size. Therefore, cells or particles of 
different sizes exit the array at different locations and can be collected separately. The main 
advantage of such a device is that it never clogs, since the distance between the pillars is 
always larger than the cells or particles they separate. This device was used to fractionate a 
mixture of different-diameter beads; 0.8, 0.9, and 1.03 µm into three distinct streams. 
Additionally, this device was used to separate a mixture of DNA molecules, 61 and 158 kb, 
in two separate trajectories. In this case an electric field of 12V/cm was used to drive the 
flow. 
Additionally, Austin group has used a variation of this chip to separate RBCs, WBCs, and 
platelets from blood plasma [87]. 
Our group has employed pillar configuration to create multiple sieving devices for size-
based separation. With these devices, we have demonstrated the isolation of cultured cancer 
cells spiked into whole blood [88]. Our devices have successively narrower gap widths 
between the columns in the direction of flows with 20, 15, 10, and 5 µm spacings all on one 
device (Figure 10). The first 20 µm wide segment disperses the cell suspension and creates 
an evenly distributed flow over the rest of the device, whereas the other segments were 
designed to retain successively smaller cells [89]. The channel depth is constant across the 
device. Two types of devices were constructed, the first type was 10 µm deep and the 
second type was 20 µm deep. As cells traversed the device, they continued through each 
region until they were stopped at a gap width that prohibited passage due to their size. 
Experiments with human whole blood, from healthy individual, proved that channels 5 µm 
wide and 10 µm deep permitted all normal cell types to cross without resistance under our 
experimental flow conditions. Cultured cancer cell lines, mixed with whole blood and 
applied to the device, were retained inside the device while all other cells migrated to the 
output reservoir.  
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Figure 9. Schematic illustrations showing the separation mechanism of sedimentation pinched-flow 
fractionation. Images a and b show enlarged views of areas (a) and (b) of the upper image, respectively. 
In the pinched segment, particles are focused onto the upper sidewall regardless of size. By applying 
sedimentation force to the flowing particles in the curved channel, particles with a higher density 
(black) migrate beyond the streamline, achieving density-based sorting. (Reprinted with permission 
from Springer publisher.) 
Eight different cancer cell line, brain neuroblasts (SK-N-MC, SK-N-AS, SK-N-SH, BE(2)-
M(17), and SH-SY5Y), breast epithelial cells (MDA231), colon epithelial cells (SW620), and 
kidney epithelial cells (HEK293), were successfully isolated from whole blood by our device. 
Additionally, either intact cells, or DNA, could be extracted for molecular analysis. DNA 
was extracted by in-situ cell lysis. After the cancer cells had been retained, the device was 
flushed for 20 min, with medium used to remove all non-retained cells, followed by water to 
lyse the retained cells and release their DNA. DNA was collected from the output reservoir 
for 20 min (approximately 0.33 mL), purified, and tested, as a demonstration that the 
captured DNA was from the cancer cell line and not a contaminant DNA from the blood 
used for spiking.  
Alternatively, retained intact cells were recovered by reversing the direction of the flow, 
using medium after allowing 20 min for them to migrate towards the outlet. Once flow was 
reversed, cells retained at the first row of transition at the 10 µm wide channels detached 
easily and traveled through the 15 µm and then the 20 µm segments, through the inlet 
reservoir, and into a collection tube. Cells were cultured from the collection tube and were 
able to proliferate, thus demonstrating the viability of the extracted cells. 
Our device was made using standard photolithography techniques and was molded in 
PDMS, polystyrene, or polyurethane [90]. 
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Figure 10. (top) Schematic showing flow direction and channel structure for the Second generation 
device having varying channel gap widths (20, 15, 10, and 5m), cells separate based on size and 
deformability. Channel depths, constant over a single device are: 20 or 10m. (Bottom) Adult blood cells 
spiked with MDA231 cells. All cells flow freely through the device except for the MDA231 cells, which 
are retained at the start of the 10µm wide channels 
A derivative of the same design was utilized to separate fetal cells from cord blood [91]. 
The device has four segments of successively narrower channels along the flow axis; these 
have 15, 10, 5, and 2.5 µm spacings. Each segment is 30 mm wide and 15 mm long and has 
375 rows of channels of the same width. Therefore, the entire device is 30mm wide and 
60mm long, giving rise to over 3.5 million channels. The channels are formed between 
pillars separated by gaps rather than a continuous structure. This design was favored to 
allow the cells to deform and resume their normal shape as they traverse the device; 
further, if the cell flow is locally slowed or if a channel becomes clogged, a cell is able to 
migrate around the affected area. Currently, a one-step centrifugation is required for 
sample preparation, and only the mononuclear layer is used in the device. This step not 
only separates most of the mature RBCs before sample loading, but it also enriches for 
fNRBCs since mononuclear cells and fNRBCs have similar densities. To identify fNRBCs, 
we stained the buffy coat with fluorescein isothiocyanate-labeled monoclonal antibody to 
HbF (green) and SYTO red. Thus, fNRBCs should fluoresce green and red. Double-stained 
samples were applied to the device. When the mononuclear layer was tested in the device, 
WBCs were retained consistently at the start of the 2.5 µm wide segment, while fNRBCs 
and mature RBCs migrated to the output reservoir. Cells were removed from the output 
reservoir, and the DNA was extracted with DNA purification kit and was tested for X and 
Y chromosomal sequence by PCR. We used cord blood from mothers who delivered male 
babies, so the X and Y chromosome could be used to demonstrate that the isolated cells 
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came from the baby and not the mother. Mature RBCs do not have a nucleus, and hence do 
not contaminate the DNA obtained [92]. 
5. Conclusion 
In the last two decades, we witnessed many advances in microfluidic devices, and many of 
these devices are in advanced development stages or are commercially available. 
Microfluidic technology offers superior capability to precisely engineer and control the 
microenvironment to sort cells. Micro- and nano-fluidic technology will fulfill the 
sensitivity, specificity, and reproducibility requirements to bring cell sorting into clinical 
utility. The challenge remains to demonstrate that information acquired using microfluidic 
devices would change the way physicians diagnose, treat, and/or monitor diseases.  
Author details 
Hisham Mohamed 
Egypt Nanotechnology Center (EGNC), Egypt 
6. References 
[1] Fisher D, Francis GE. and Rickwood D. Cell Separation. New York: Oxford; 1998. 
[2] Wheeler AR, Throndset WR, Whelan RJ, Leach AM, Zare RN, Liao YH, Farrell K, 
Manger ID, Daridon A. Microfluidic Device for Single-Cell Analysis. Anal. Chem. 
2003:75 (14) 3581–3586. 
[3] Horan PK, Wheeless LL. Quantitative single cell analysis and sorting Science 1977: (198) 
149-157. 
[4] Dino Di Carlo DD, Lee LP. Dynamic Single-Cell Analysis for Quantitative Biology. 
Anal. Chem. 2006: 78 (23) 7918–7925 
[5] Anselmetti D. Single Cell Analysis. Hoboken: Wiley: 2009 
[6] Iorgulescu DG, Kiroff GK. Minimal residual marrow disease: detection and significance 
of isolated tumour cells in bone marrow. ANZ J Surg. 2001: (71) 365-376. 
[7] Engell HC. Cancer cells in the circulating blood. Acta Chir. Scand. 1955: (Suppl) (210), 
1955. 
[8] Vlems F A, Wobbes T, Punt CJ, Van Muijen GN. Detection and clinical relevance of 
tumor cells in blood and bone marrow of patients with colorectal cancer. Anticancer 
Res. 2003: (23) 523-530. 
[9] Gomez FA. Biological Applications of Microfluidics. Hoboken:Wiley; 2008. 
[10] Kumar CS. Microfluidic Devices In Nanotechnology. Hoboken: Wiley; 2010. 
[11] Polla DL, Erdman AG, Robbins WP, Markus DT, Diaz-Diaz J, Rizq R, Nam Y, Brickner 
HT, Krulevitch P, Wang A. Microdevices in medicine. Annual Review of Biomedical 
Engineering 2000: (2) 552-572.  
 
Blood Cell – An Overview of Studies in Hematology 222 
[12] Chou C, Austin RH, Bakajin O, Tegenfeldt JO, Castelino JA, Chan SS, Cox EC, 
Craighead, H, Darnton N, Duke T, Han J, Turner S. Sorting biomolecules with 
microdevices.. Electrophoresis 2000: (21) 81-90. 
[13] Lee TMH, Hsing I, Lao AIK, Carles MC. A miniaturized DNA amplifier: its application 
in traditional chineses medicine. Anal Chem, 2000: (72) 4242-4247. 
[14] Simpson JL, Elias S. Isolating fetal cells from maternal blood: Advances in prenatal 
diagnosis through molecular technology. JAMA 1993: (270) 2357-2361. 
[15] McCormick RM, Nelson RJ, Alonso-Amigo MG, Benvegnu DJ, Hooper HH. 
Microchannel electrophoretic separations of DNA in injection-molded plastic 
substrates. Anal Chem. 1997: (69) 2626-2630. 
[16] Lagally ET, Medintz I, Mathies RA. Single-molecule DNA amplification and analysis in 
an integrated microfluidic device. Anal Chem. 2001: (73) 565-570. 
[17] Koch M, Evans A, Brunnschweiler A. Microfluidic Technology and Applications. 
Hertfordshire: Research Studies Press LTD: 2000. 
[18] Saliterman SS. BioMEMS and Medical Microdevices. Bellingham: SPIE Press; 2006. 
[19] Bunn HF, Aster JC. Pathophysiology of Blood Disorders. Boston: McGrawy Hill: 2010. 
[20] Stuart M, Nagel R. Sickle-cell disease. The Lancet 2004: 364 (9442) 1343-1360 
[21] Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Molecular and cellular 
changes associated with the acquisition of metastatic ability by prostatic cancer cells. 
Prostate 1994: (25) 249-265. 
[22] Pienta KJ, Coffey DS. Nuclear-cytoskeletal interactions: evidence for physical 
connections between the nucleus and cell periphery and their alteration by 
transformation. J Cell Biochem. 1992: (49) 357-365. 
[23] Nickerson JA. Nuclear dreams: the malignant alteration of nuclear architecture. J Cell 
Biochem. 1998: (70) 172-180. 
[24] Pawlak G, Helfman D M. Cytoskeletal changes in cell transformation and 
tumorigenesis. Curr Opin Genet Dev. 2001: (11) 41-47. 
[25] Konety BR, Getzenberg RH. Nuclear structural proteins as biomarkers of cancer. J Cell 
Biochem, Suppl 1999: (32-33) 183-191. 
[26] Backman V, Wallace MB, Perelman LT, Arendt JT, Gurjar R, Muller MG, Zhang Q, 
Zonios G, Kline E, McGilligan JA, Shapshay S, Valdez T, Badizadegan K, Crawford JM, 
Fitzmaurice M, Kabani S, Levin HS, Seiler M, Dasari RR, Itzkan I, Van Dam J, Feld MS, 
McGillican T. Detection of preinvasive cancer cells. Nature 2000: (406) 35-36. 
[27] Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A, Boumsell L, D Buckley C, 
Bühring HJ, Clark G, Engel P, Fox D, Jin BQ, Macardle PJ, Malavasi F, Mason D, 
Stockinger H, Yang X. CD molecules 2006--human cell differentiation molecules. J 
Immunol Methods 2007: 318 (1–2) 1–5. 
[28] Went P, Lugli A., Meier S , Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent 
EpCam Protein Expression in Human Carcinomas. Human Pathology 2004: (35) 122-
128. 
[29] Gastl G, Spizzo G, Obrist P, Dunser M, Mikuz G. Ep-CAM overexpression in breast 
cancer as a predictor of survival. The Lancet 2000: (356) 1981-1082. 
 
Use of Microfluidic Technology for Cell Separation 223 
[30] Spizzo G, Gastl G, Wolf D, Gunsilius E, Steurer M, Fong D, Amberger A, Margreiter R, 
Obrist P. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast 
cancer and its impact on survival. Br Jr Cancer 2003: (88) 574-587. 
[31] Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, 
Castelberg B, Bart R, Stopatschinskaya S, Kochli O, Haas P, Mross F, Zuber M, Dietrich 
H, Bischoff S, Mirlacher M, Sauter G, Gastl G. High Ep-CAM expression is associated 
with poor prognosis in node positive breast cancer. Breast Cancer Research and 
Treatment 2004: (89) 207-213. 
[32] Talasaz AH, Powell AA, Huber DE. Berbee JG, Roh KH, Yu W, Xiao W, Davis MM, 
Pease RF, Mindrinos MN, Jeffrey SS, Davic RW. Isolating highly enriched populations 
of circulating epithelial cells and other rare cells from blood using a magnetic sweeper 
device. PNAS 2009: (106) 10 3970-3975. 
[33] Kovacs GTA. Micromachined Transducers Sourcebook. Boston: McGraw Hill; 1998 
[34] Madou MJ. Fundamentals of Microfabrication 2nd edn. Boca Raton: CRC Press: 2002. 
[35] Coventor Inc. Http://coventor.com/ (accessed 29 April 2012). 
[36] ANSYS. Http://ansys.com/ (accessed 29 April 2012). 
[37] COMSOL. Http://comsol.com/ (accessed 29 April 2012). 
[38] Mohamed H, McCurdy LD, Szarowski DH, Duva S, Turner JN, Caggana M. 
[39] IEEE Trans. NanoBio. Sci. 2004: (3) 251-256. 
[40] Sin A, Murthy SK, Revzin A, Tompkins RG, Toner M. Enrichment Using Antibody-
Coated Microfluidic Chambers in Shear Flow: Model Mixtures of Human Lymphocytes. 
Biotechnology and Bioengineering 2005; 91(7) 817-826. 
[41] Fu AY, Chou HP, Spence C, Arnold FH, Quake SR. An Integrated Microfabricated Cell 
Sorter. Anal. Chem. 2002: 74 (11) 2451–2457. 
[42] Revzin A, Sekine K, Sin A, Tompkins RG, Toner M. Development of a microfabricated 
cytometry platform for characterization and sorting of individual leukocytes. Lab on a 
chip 2005: (5) 30-37. 
[43] Chang WC, Lee LP, Liepmann D. Biomimetic technique for adhesion-based collection 
and separation of cells in a microfluidic channel. Lab on a chip 2005: (5) 64-73. 
[44] Madrusov E, Houng A, Klein E, Leonard EF. Membrane-based cell affinity 
chromatography to retrieve viable cells. Biotechnol Prog 1995: (11) 208-213 
[45] Malmstadt N, Yager P, Hoffman AS, Stayton PS. A Smart Microfluidic Affinity 
Chromatography Matrix Composed of Poly(N-isopropylacrylamide)-Coated Beads. 
Anal. Chem 2003: 75 (13) 2943-2949. 
[46] Kruger J, Singh K, O’Neill A, Jackson C, Morrison A, O’Brien P. Development of a 
microfluidic device for fluorescence activated cell sorting. J. Micromech. Microeng. 
2002: (12) 486–494. 
[47] Dittrich PS, Schwille P. An Integrated Microfluidic System for Reaction, High-
Sensitivity Detection, and Sorting of Fluorescent Cells and Particles. Anal. Chem. 2003: 
(75) 5767-5774. 
[48] Chung TD, Kim HC. Recent advances in miniaturized microfluidic flow cytometry for 
clinical use. Electrophoresis 2007: (28) 4511–4520. 
 
Blood Cell – An Overview of Studies in Hematology 224 
[49] Miyake R, Ohki H, Yamazaki I, Takagi T. Investigation of sheath flow chambers for 
flow cytometers (micromachined flow chamber with low pressure loss). JSME Int. J. B 
1997: 40) 106–13. 
[50] Huh D, Gu W, Kamotani Y, Grotberg JB, Takayama S. Microfluidics for flow cytometric 
analysis of cells and particles. Physiol. Meas. 2005: (26) R73–R98. 
[51] Altendorf E, Zebert D, Holl M, Yager P. Differential blood cell counts obtained using a 
microchannel based flow cytometer. Transducers 1997: (97) 531–534. 
[52]  Fu AY, Spence C, Scherer A, Arnold FH, Quake SR. A microfabricated fluorescence-
activated cell sorter. Nature Biotechnology 1999: (17) 1109-1111 
[53] Oakey J, Allely J, Marr DWM. Laminar-Flow-Based Separations at the Microscale. 
Biotechnol. Prog. 2002: (18) 1439-1442.  
[54] Johansson L, Nikolajeff F, Johansson S, Thorslund S. On-Chip Fluorescence-Activated 
Cell Sorting by an Integrated Miniaturized Ultrasonic Transducer. Anal. Chem. 2009: 
(81) 5188–5196 
[55] Chun H, Chung TD, Kim HC, Cytometry and Velocimetry on a Microfluidic Chip 
Using Polyelectrolytic Salt Bridges. Anal. Chem. 2005: (77) 2490-2495. 
[56] Pamme N. Magnetism and microfluidics. Lab on a chip 2006: (6) 24-38. 
[57] Han KH, Frazier B. Paramagnetic capture mode magnetophoretic microseparator for 
high efficiency blood cell separations. Lab on a Chip 2006: (6) 265-273 
[58] Qu BY,Wu ZY, Fang F, Bai ZM, Yang DZ, Xu SK. A glass microfluidic chip for 
continuous blood cell sorting by a magnetic gradient without labeling. Anal Bioanal 
Chem 2008: (392) 1317–1324. 
[59] Adams JD, Kimb U, Sohb HT. Multitarget magnetic activated cell sorter. PNAS 2008: 
105 (47) 18165–18170. 
[60] Xia N, Hunt TP, Mayers BT, Alsberg E, Whitesides GM, Westervelt RM, Ingber DE. 
Combined microfluidic-micromagnetic separation of living cells in continuous flow. 
Biomed Microdevices 2006: (8) 299–308. 
[61] Modak N, Datta A, Ganguly R. Cell separation in a microfluidic channel using magnetic 
microspheres. Microfluid Nanofluid 2009: (6) 647–660. 
[62] Lee H, Purdon AM, Westervelta RM. Manipulation of biological cells using a 
microelectromagnet matrix. Applied Physics Letters 2004: (85) 1063-1065.  
[63] Salibaa AE, Saiasa L, Psycharia E, Minca N, Simonb D, Bidardc FC, Mathiotd C, Piergac 
JY, Fraisierf V, Salamerof J, Saadag V, Faraceg F, Vielhg P, Malaquina L, Jean-Louis 
Viovya JL. Microfluidic sorting and multimodal typing of cancer cells in self-assembled 
magnetic arrays. PNAS 2010: (107) 33 14525-14529. 
[64] Kose AR, Koser H. Ferrofluid mediated nanocytometry. Lab on a Chip 2012: (12) 190-
196. 
[65] Li, D Electrokinetics in microfluidics, 1st edition, vol. 2, Elsevier, Amsterdam (2004). 
[66] Al-Abboodi A, Tjeung R, Doran P, Yeo L, Friend J, Chan P. Microfluidic chip containing 
porous gradient for chemotaxis study. Proc. of SPIE 2011: (8204) H1-H6 
[67] Agrawal N, Toner M, Irimia D. Twelfth International Conference on Miniaturized 
Systems for Chemistry and Life Sciences: conference proceedings, October 12-16, 2008, 
San Diego, California, USA. 
 
Use of Microfluidic Technology for Cell Separation 225 
[68] Chen YC, Lou X, Ingram P, Yoon E. The 15th International Conference on Miniaturized 
Systems for Chemistry and Life Sciences: conference proceedings, October 2-6, 2011, 
Seattle, Washington. 
[69] Englert DL, Manson MD, Jayaraman A. Flow-Based Microfluidic Device for 
Quantifying Bacterial Chemotaxis in Stable, Competing Gradients. Applied and 
Enviromental Microbiology 2009: (75) 4557–4564 
[70] Walker GM, Sai J, Richmond A, Stremler M, Chung CY, Wikswo JP. Effects of flow and 
diffusion on chemotaxis studies in a microfabricated gradient generator. Lab on a Chip 
2005: (5) 611-618. 
[71] MacDonald MP, Spalding GC, Dholakia K. Microfluidic sorting in an optical lattice. 
Nature 2003: (426) 421-424. 
[72] Kovac JR, Voldman J. Intuitive, Image-Based Cell Sorting Using Optofluidic Cell 
Sorting. Anal. Chem. 2007: (79) 9321-9330. 
[73] Shirasaki Y, Tanaka J, Makazu H, Tashiro K, Shoji S, Tsukita S, Funatsu T. On-Chip Cell 
Sorting System Using Laser-Induced Heating of a Thermoreversible Gelatin Polymer to 
Control Flow. Anal Chem 2006: (78) 695-701. 
[74] Lin CC, Chen A, Kin CH. Microfluidic cells counter/sorter utilizing multiple particle 
tracing technique and optically switching approach. Biomed Microdevices 2008: (10) 55-
63. 
[75] Hwang H, Park JK. Optoelectrofluidic platforms for chemistry and biology. Lab on a 
Chip 2011: (11) 33-47. 
[76] Wang MM, Tu E, Raymond DE, Yang MJ, Zhang H, Hagen N, Dees B, Mercer EM, 
Forster AH, Kariv I, Marchand PJ, Butler W. Nature Biotechnology 2004: (23) 83-87. 
[77] Pommer MS, Zhang Y, Keerthi N, Chen D, Thomson JA, Meinhard CD, Soh, HT. 
Dielectrophoretic separation of platelets from diluted whole blood in microfluidic 
channels. Electrophoresis 2008: (29) 1213-1218.  
[78] Hu X, Bessette PH, Qian J, Meinhard CD, Daugherty PS, Soh HT. Marker-specific 
sorting of rare cells using dielectrophoresis. PNAS 2005: (102) 44 15757-15761. 
[79] Vahey MD, Voldman J. An Equilibrium Method for Continuous-Flow Cell Sorting 
Using Dielectrophoresis. Anal Chem 2008: (80) 3135-3143.  
[80] Lapizco-Encinas BH, Simmons BA, Cummings EB, Fintschenko Y. Dielectrophoretic 
Concentration and Separation of Live and Dead Bacteria in an Array of Insulators. Anal 
Chem 2004: (76) 1571-1579. 
[81] Morijiri T, Sunahiro S, Senaha M, Yamada M, Seki M. Sedimentation pinched-flow 
fractionation for size- and density-based particle sorting in microchannels. Microfluid 
Nanofluid 2011: (11) 105-110. 
[82] Wilding P, Kricka LJ, Cheng J, Hvichia G, Shoffner MA, Fortina P. Integrated cell 
isolation and polymerase chain reaction analysis using silicon microfilter chambers. 
Anal Biochem 1998: (257) 95-200. 
[83] Yuen PK, Kricka LJ, Fortina P, Panaro PJ, Sakazume T, Wilding P. Microchip module 
for blood sample preparation and nucleic acid amplification reactions. Genome Res 
2001: (11) 405-412. 
 
Blood Cell – An Overview of Studies in Hematology 226 
[84] Panaro NJ, Lou XJ, Fortina P, Kicka LJ, Wilding P. Micropillar array chip for integrated 
white blood cell isolation and PCR. Biomed Eng 2005: (21) 157-162. 
[85] Cabodi M, ChenYF, Turner SWP, Craighead HG, Austin RH. Continuous separation of 
biomolecules by the laterally asymmetric diffusion array with out-of-plane sample 
injection. Electrophoresis 2002: (23) 3496–3503. 
[86] Huang LR. Cox EC, Austin RH, Sturm JC. Continuous Particle Separation Through 
Deterministic Lateral Displacement. Science 2004: (304) 987-990. 
[87] Davis JA, Inglis DW, Morton KJ, Lawrence DA, Huang LR, Chou SY, Sturm JC, Austin 
RH. Deterministic hydrodynamics: Taking blood apart. PNAS 2006: 103 (40) 14779–
14784. 
[88] Mohamed H, McCurdy LD, Szarowski DH, Duva S, Turner JN, Caggana M. 
Development of a Rare-Cell Fractionation Device: Application for Cancer Detection. 
IEEE Transactions on NanoBioscience 2004: (3) 251-256. 
[89] H. Mohamed, M. Murray, J. N. Turner, and M. Caggana, “Circulating tumor cells: 
capture with a micromachined device,” Proceedings of the 2005 NSTI Bio Nano 
Conference, vol1, pp. 1-4, 2005. 
[90] Mohamed H, Murray M, Turner JN, Caggana M. Isolation of tumor cells using size and 
deformation. Journal of Chromatography A 2009: (1216) 8289–8295. 
[91] H. Mohamed, J. N. Turner, and M. Caggana. Bio Nano Conference: conference 
proceedings, May 7-11, 2006, Hynes Convention Center, Boston Massachusetts. 
[92] Mohamed H, Turner JN, Caggana M. Bio Nano Conference: conference proceedings, 
May 20-24, 2007, Santa Clara, California. 
[93] Murthy SK, Sethu P,Vunjak-Novakovic G, Toner M, Radisic M. Size-based microfluidic 
enrichment of neonatal rat cardiac cell populations. Biomed Microdevices 2006: (8) 231–
237. 
[94] Huang R, Barber TA, Schmidt MA, Tompkins RG, Toner M, Bianchi DW, Kapur R, 
Flejter WL. A microfluidics approach for the isolation of nucleated red blood cells 
(fNRBCs) from the peripheral blood of pregnant women. Prenat Diagn. 2008: (28) 892–
899. 
